Safety and efficacy of ruxolitinib in patients with myelofibrosis: A retrospective study
Latest Information Update: 07 Aug 2021
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Therapeutic Use
- 07 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association